Home
Conditions
Treatments
Trials
Explore
š
/
treatments
/
90Yttrium-Ibritumomab Tiuxetan (ZevalinĀ®)+Rituximab
/
mega-study
90Yttrium-Ibritumomab Tiuxetan (ZevalinĀ®)+Rituximab